Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Eiger BioPharmaceuticals Europe Limited

COURT
Texas Northern Bankruptcy Court
CASE NUMBER
8:2024bk80043
TYPE / CHAPTER
Voluntary / 11

Subscribe to This Case

Follow this case and receive case update emails for the life of this case for a one-time fee of $39.95.

Case Information

This case has a LEAD CASE: Eiger BioPharmaceuticals, Inc.

When following such a bankruptcy, it is important to follow the lead case. When we detect a group of jointly administered cases, we mark the associated and lead cases. The case information tab of the case page will show whether a case is associated with a lead case, or is a lead case and has associated cases.

Filed

4-1-24

Updated

4-2-24

Last Checked

4-2-24

Assets

Subscribe

Liabilities

Subscribe

Get notified when your customers file for bankruptcy

Docket

Last Updated
Apr 2, 2024
Last Entry Filed
Apr 1, 2024

Docket Entries by Week of Year

Apr 1 1 Petition Non-individual Chapter 11 Voluntary Petition. Fee Amount $1738 Filed by Eiger BioPharmaceuticals Europe Limited Chapter 11 Plan due by 07/30/2024. Disclosure Statement due by 07/30/2024. (Califano, Thomas)
Apr 1 Receipt of filing fee for Voluntary petition (chapter 11)( 24-80043-11) [misc,volp11a] (1738.00). Receipt number A31284791, amount $1738.00 (re: Doc# 1). (U.S. Treasury)
Apr 1 2 Motion for joint administration of cases 24-80040 (SGJ); 24-80041 (SGJ); 24-80042 (SGJ); 24-80043 (SGJ); 24-80044 (SGJ) Debtors Emergency Motion for Entry of an Order Directing Joint Administration of Chapter 11 Cases Filed by Debtor Eiger BioPharmaceuticals Europe Limited (Attachments: # 1 Exhibit A) (Califano, Thomas)

Case Information

Court
Texas Northern Bankruptcy Court
Case number
8:2024bk80043
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Chapter
11
Filed
Apr 1, 2024
Type
voluntary
Updated
Apr 2, 2024
Last checked
Apr 2, 2024
Lead case
Eiger BioPharmaceuticals, Inc.

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Eiger BioPharmaceuticals Europe Limited
    30 Upper High Street
    Thame
    Oxfordshire OX9 3EZ
    OUTSIDE U. S.
    United Kingdom

    Represented By

    Thomas Robert Califano
    Sidley Austin LLP
    787 Seventh Avenue
    New York, NY 10019
    212-839-5575
    Fax : 212-839-5599
    Email: tom.califano@sidley.com

    U.S. Trustee

    United States Trustee
    1100 Commerce Street
    Room 976
    Dallas, TX 75202
    214-767-8967